Delivered-To: tjphuhs@gmail.com Received: by 2002:a05:6000:2188:b0:43d:781a:c227 with SMTP id ef8csp93250wrb; Fri, 17 Apr 2026 08:33:44 -0700 (PDT) X-Received: by 2002:ac8:7f16:0:b0:50d:7135:5631 with SMTP id d75a77b69052e-50e368281ecmr48218111cf.6.1776440023896; Fri, 17 Apr 2026 08:33:43 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1776440023; cv=none; d=google.com; s=arc-20240605; b=N8CHNcJLnqRc73XVJwwViCkJ1BLrWuoAzIIFTuCyPw+iluZvZLlLUGpvUtf7KQ0tO2 fCXrdw6bFpSnsmR/le14DaMovjD0SsEmd8tgwP4y6o6MChoMwgjILpte2MhIUDTI9Exk Plb5PNoXH1hqCBj1mkav/XBQXkwBEKdPsfz1+HJ7YK+wJ0y+JoBgPuujPfGUpj89Zhel RYTWxN082FHU4fYKtlPEbFeWUN1J3QklnFagq9GwC/xo1MxhLpaNXorNBFcpZVWmh9Rz d+VZggrIMBrnReThP1WP+Hn0jRXuQ3YGVoWdKgTKGIVX0D1Nxasi5YtzuCiTdtCXWQ88 Rquw== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=message-id:list-unsubscribe-post:list-unsubscribe:feedback-id:to :from:subject:mime-version:date:sender:dkim-signature:dkim-signature :dkim-signature; bh=UO0RkVDib6XIQgQMD0t4IpZ91RIq0HHj2d6bADKIPm0=; fh=9zP21OW67FFZD2VV42mGudo540Qp4aalMWxJB5kMYug=; b=XFRNFF4mZ9LAIAPJUpZ0xZFhvFmLqmM1wJR6Qln8LPiNwrxP6Q4iXiyRH4qrstd1k8 nhN/P8q8o6VKxvtmz5W+QBt50wqsjU0ONn6JGlf+mjLLJrZf7eqjJpX9LNs90D8de203 PGvr7TbxKdA9KXCyQBhNAO7m8fhR8IkuPAuRNsBSCfqxCvwZfp3v+eGHB7EV8drOkL3/ 8v9bfJMw3kq9NGDIbF/Bfqq4hIbzvSwMaS2cfWIfTgmD8OsNVuxJbbBq6QWi9SS8/5Up 0BdfsfTLcMiVxQXkF4byJH7YFotH9zgLgUpPbFWpXBjsN7UFB0vTnHwqDIKIX0dW8nu6 Nueg==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@dkim1.omnisend.email header.s=omni1 header.b=E9FUD2sj; dkim=pass header.i=@somachems.com header.s=smtp header.b=i2lnJwjt; dkim=pass header.i=@mailgun.org header.s=mg header.b=ZaIsG2Jw; spf=pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.8 as permitted sender) smtp.mailfrom="bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com"; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=somachems.com Return-Path: Received: from g8.gb126d70.use4.send.mailgun.net (g8.gb126d70.use4.send.mailgun.net. [204.220.169.8]) by mx.google.com with UTF8SMTPS id d75a77b69052e-50e3949628bsi21476841cf.199.2026.04.17.08.33.43 for (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128); Fri, 17 Apr 2026 08:33:43 -0700 (PDT) Received-SPF: pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.8 as permitted sender) client-ip=204.220.169.8; Authentication-Results: mx.google.com; dkim=pass header.i=@dkim1.omnisend.email header.s=omni1 header.b=E9FUD2sj; dkim=pass header.i=@somachems.com header.s=smtp header.b=i2lnJwjt; dkim=pass header.i=@mailgun.org header.s=mg header.b=ZaIsG2Jw; spf=pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.8 as permitted sender) smtp.mailfrom="bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com"; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=somachems.com DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=dkim1.omnisend.email; q=dns/txt; s=omni1; t=1776440023; x=1776447223; h=Message-Id: List-Unsubscribe-Post: List-Unsubscribe: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=UO0RkVDib6XIQgQMD0t4IpZ91RIq0HHj2d6bADKIPm0=; b=E9FUD2sj/tTAa+45RiqzJePokwv1io60EZqlXaVk0IAhd0DuBpKdslrHNempLM5VzE/J4HS4piV46kWAKTTgHLR8LkCGasGTX2Ohl38KnMHpBu5SXOr16t3Govhb36TPMJzvE8g+fd/wAnYL/zwx1YYJyVr61+4CVXyZKqimrXZA13SHJW/UaiSJBM5DcWwif7gprIM8TgoOpOifhtsiKowunP4gjTKvPHBfu9EDE0XQiARJ3fOOp/2BF8pGMS8EYA6xeRIKXltn/9YWWxW8YwXaCiorpYf1cq6kWGj581XSEgU58YAw/XAgbwm4p+PLh5e6G7UMMI88jtMgxBkf6g== DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=somachems.com; q=dns/txt; s=smtp; t=1776440023; x=1776447223; h=Message-Id: List-Unsubscribe-Post: List-Unsubscribe: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=UO0RkVDib6XIQgQMD0t4IpZ91RIq0HHj2d6bADKIPm0=; b=i2lnJwjtmaNlxJSPuyXJXzrDYCsxyIdIlpZFedFRJioobsVqLz5b/86SMpij8a6US2GlqPmNwPnaPHfQ7tj4MDQXUifzxWp9wI6k2Dtb5QJGJ+XNaRSMfxA5cFmFFFrfGDG7fJ+QFieiCdQgStTUCjhB7a1vbgaQ/D8MPbepxCA= DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=mailgun.org; q=dns/txt; s=mg; t=1776440023; x=1776447223; h=Message-Id: List-Unsubscribe-Post: List-Unsubscribe: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=UO0RkVDib6XIQgQMD0t4IpZ91RIq0HHj2d6bADKIPm0=; b=ZaIsG2JwICmJpkEZiVvU73cQ2U6aU/fqfEpiQj/UcGiDYfXhEnbug/tZ6vEvsmY5J8+Rcdt4ZOsbF15pPLZ5fJd3awV8WJvCBJwjC6uGqGic91BKnvwiDYEyaNAStD2twE5sh4lbcWEXxw44Onm6jG2641PlocE6qFkeOXjLgr0= X-Mailgun-Sid: WyJkMGJjMCIsInRqcGh1aHNAZ21haWwuY29tIiwiNzk2ZDQ5Il0= X-Feedback-Id: info@somachems.com:secondary-dkim-signed:686788436b43ce5dfdf26b4b:mailgun Received: by ad794592dd85f368b5108f2f32e91ed6bf60526a26de09a3f79cc60523648fc0 with HTTP id 69e252d21e02d796a0cb72f3; Fri, 17 Apr 2026 15:33:35 GMT X-Mailgun-Sending-Ip-Pool-Name: BstS X-Mailgun-Sending-Ip-Pool: 665596289f43bfa346f3584f X-Mailgun-Sending-Ip: 204.220.169.8 X-Mailgun-Batch-Id: 69e252cf05bf5e60b7f34daf Sender: info@somachems.com Date: Fri, 17 Apr 2026 15:33:35 +0000 Mime-Version: 1.0 Content-Type: multipart/alternative; boundary="95ef3b4d5cd57af86c876b7b96e57e4fd87eb9e9b1df112419925d074af9" Subject: =?UTF-8?q?=F0=9F=A7=A0_P21_-_The_Nootropic_Peptide_You_Haven't_Heard_Of_?= =?UTF-8?q?=F0=9F=A7=A0?= From: SOMA CHEMS To: tjphuhs@gmail.com X-Mailgun-Tag: secondary-dkim-signed X-Mailgun-Track: false X-Mailgun-Secondary-Dkim: dkim1.omnisend.email,omni1 Feedback-Id: 69de9bbb07d98f486a94fd77:686794eb7d5d9b4678a0be3a:campaign:omnisend List-Unsubscribe: List-Unsubscribe-Post: List-Unsubscribe=One-Click X-Mailgun-Variables: {"brandID": "686794eb7d5d9b4678a0be3a", "contactID": "68a3ebb905e51bffe64c8eaf", "progressID": "69dfafa0e864247452b3b301"} Message-Id: <20260417153335.3551ccc0eabc8f9d@somachems.com> --95ef3b4d5cd57af86c876b7b96e57e4fd87eb9e9b1df112419925d074af9 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable This email was sent to you as HTML-only. To view it, please visit:=20 https://qfq.soundestlink.com/ce/v/68a3ebb905e51bffe64c8eaf/69dfafa0e8642474= 52b3b301 ************************** Make sure you keep getting our latest offers and add info@somachems.com to = your address book. Unsubscribe=20 https://qfq.soundestlink.com/contactsPreferences/v2/unsubscribe/?b=3D686794= eb7d5d9b4678a0be3a&c=3D68a3ebb905e51bffe64c8eaf&payload=3DgExiopZMhLUve6miX= lseUAvh0EHEvFlYa13DCZXrG0nrfwc8LiPQZApJxaxj6cRZwV4Mcc4qzfvsaWECxRRgVXWu1AHY= UBDCtyR3xWpdDIuGtr7l9xUmDzxARXrCSMUQnl24 Visit site https://somachems.com =C2=96 --95ef3b4d5cd57af86c876b7b96e57e4fd87eb9e9b1df112419925d074af9 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable =F0=9F=A7=A0 P21 - The Nootropic Peptide You Haven't Heard Of = =F0=9F=A7=A0

= 3D""
=
3D""

P21 is a synthetic peptide deri= ved from Cerebrolysin, a neuropeptide mixture studied for = its effects on brain repair and cognitive function. It has= gained attention in neuroscience research for its ability to promote neurogenesis, synaptic formation, and long-term brain r= ecovery without the complexity of multi-compound formulations.

=


Unlike many nootropics that tem= porarily enhance neurotransmitters, P21 is being studied for its ability to= rebuild and protect neural tissue, making it a promising = tool in models of brain injury, cognitive decline, and neurodegeneration.


Let's dig into it!

3D""
GET I= T HERE

HOW DOES IT HELP?=

P21 works by stimulating neurotrophic fac= tors, particularly pathways related to BDNF. This= leads to:

  • Increased neuron growth and differentiati= on
  • Enhanced synaptic plasticity and connecti= vity
  • Improved memory formation and cognitive p= rocessing
  • Protection against oxidative stress &= neuronal damage

In experimental models, P21 has shown the ability= to support long-term brain repair. This makes it especial= ly relevant in traumatic brain injury, age-related cognitive functi= on decline and neuroinflammation resear= ch.

WHAT ARE THE RISKS?

Research on P21 is still relati= vely limited, but early findings suggest a low side effect profile<= /strong>. Observed effects may include:

  • Mild headache or= mental fatigue during early exposure
  • Temporary ov= erstimulation or restlessness 
  • Shifts in neur= otransmitter balance with prolonged use

No major toxicity or organ-rela= ted issues have been reported in preclinical data, though long-term safety = is still being evaluated. As with all compounds in its category, P21 is int= ended strictly for research use only and not for human or = veterinary application.
3D""
GET I= T HERE

WHAT KIND OF RESEARCHER = IS IT FOR?

P21 is ideal for researchers st= udying:

  • Neurogenesis and brain repair
  • <= strong>Memory formation and cognitive enhancement
  • = Traumatic brain injury and recovery models
  • Neurode= generative conditions such as Alzheimer=E2=80=99s or Parkinson=E2=80=99s
  • Long-term neural plasticity and synaptic resilience<= /strong>

It is particularly valuable in = models where the goal is to restore or rebuild brain function, rather than simply stimulate it. For researchers focused on de= ep neurological recovery and cognitive resilience, P21 offers a un= ique and promising approach.


If you are conducting research = in those fields, you can order P-21 in 10mg v= ials through our website (sold for research/laboratory use on= ly).

GET P= 21 HERE

LOOKING FOR OTHER PRODUCTS?

SOMA CHEMS offers well ove= r 100 research compounds, including Selective AR Modulators, Peptides, Amin= os, Research Oils and Nootropics, among many others - <= span style=3D"color:rgb(255,255,255);font-size:16px;">Visit the link below to di= scover our extensive product selection!

SOMAC= HEMS.COM
<= td style=3D"font-size:0;line-height:0;border-top:2px solid #fff;"> 

Edit Preferences or Unsubscribe

=C2=A9 Soma


4703 W 30th Street, Indianapolis, United States, 4= 6222


This email was sent to tjphuhs@gmail.com because y= ou've subscribed on our site or made a purchase.

--95ef3b4d5cd57af86c876b7b96e57e4fd87eb9e9b1df112419925d074af9--